Concepedia

Author

Fandong Kong

Capital Medical University

Also Known As

F.-D. Kong, Fan-dong Kong, Fandong Kong

13

Publications

237

Citations

6

H-Index

0

Concepts

All Affiliations

Capital Medical UniversityBeijing Chao-Yang HospitalPeking UniversityThe First Affiliated Hospital, Sun Yat-sen UniversitySun Yat-sen University
FK

About

Fandong Kong is an author at Capital Medical University.

Fandong Kong

×

5

Publications

221

Citations

5

H-Index

YearCitations

Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways

Shuying Dong, Jian Kong, Fandong Kong,

Journal of Translational Medicine

2013

80

YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma

Jian Kong, Fandong Kong, Jun Gao,

Molecular Cancer

2014

49

Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation

Shuying Dong, Jian Kong, Fandong Kong,

BMC Cancer

2015

46

Low Concentration of Caffeine Inhibits the Progression of the Hepatocellular Carcinoma <i>via Akt</i> Signaling Pathway

Shuying Dong, Jian Kong, Jinge Kong,

Anti-Cancer Agents in Medicinal Chemistry

2015

26

Identification and Comprehensive Analysis of FREM2 Mutation as a Potential Prognostic Biomarker in Colorectal Cancer

Hanpeng Du, Haiyue Wang, Fandong Kong,

Frontiers in Molecular Biosciences

2022

20

Page 1